Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial

Published:2020-09-29 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Usmani Salman Sadullah,Raghava Gajendra P. S.

Funder

Department of Science and Technology, Ministry of Science and Technology, India

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference71 articles.

1. “Coronavirus Disease (COVID-19)”,2020

2. Coronavirus: A visual guide to the economic impact;Lora Jones;BBC NEWS,2020

3. Scores of coronavirus vaccines are in competition - how will scientists choose the best;Callaway;Nature,2020

4. A Review of SARS-CoV-2 and the Ongoing Clinical Trials;Tu;Int J Mol Sci,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Web-Based Method for the Identification of IL6-Based Immunotoxicity in Vaccine Candidates;Computational Vaccine Design;2023

2. Changes of Host Immunity Mediated by IFN-γ+ CD8+ T Cells in Children with Adenovirus Pneumonia in Different Severity of Illness;Viruses;2021-11-28

3. COVID‐19 vaccines and nanomedicine;International Journal of Dermatology;2021-06-05

4. A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2020-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP